EA201791369A1 - Твердые формы конденсированных гетероароматических пирролидинонов - Google Patents

Твердые формы конденсированных гетероароматических пирролидинонов

Info

Publication number
EA201791369A1
EA201791369A1 EA201791369A EA201791369A EA201791369A1 EA 201791369 A1 EA201791369 A1 EA 201791369A1 EA 201791369 A EA201791369 A EA 201791369A EA 201791369 A EA201791369 A EA 201791369A EA 201791369 A1 EA201791369 A1 EA 201791369A1
Authority
EA
Eurasian Patent Office
Prior art keywords
solid forms
condensed heteroaromatic
chemical compounds
pyrrolidinones
heteroaromatic pyrrolidinones
Prior art date
Application number
EA201791369A
Other languages
English (en)
Other versions
EA032291B1 (ru
Inventor
Жунлян Чэнь
Томонори Итибакасе
Чуньжун Ма
Кристофер Мэттьюс
Хадзиме Мотойоси
Колин О'Брайан
Кентаро Ядзи
Наоки Йосикава
Original Assignee
Такеда Фармасьютикал Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55299676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201791369(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Такеда Фармасьютикал Компани Лимитед filed Critical Такеда Фармасьютикал Компани Лимитед
Publication of EA201791369A1 publication Critical patent/EA201791369A1/ru
Publication of EA032291B1 publication Critical patent/EA032291B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)

Abstract

Описаны химические соединения, которые представляют собой ингибиторы селезеночной тирозинкиназы, а именно химические соединения, содержащие 6-((1R,2S)-2-аминоциклогексиламино)-7-фтор-4-(1-метил-1Н-пиразол-4-ил)-1Н-пирроло[3,4-с]пиридин-3(2H)-он, а также их некоторые твердые формы. Описаны также способы применения указанных химических соединений для лечения расстройств, таких как рак.
EA201791369A 2014-12-18 2015-12-17 Твердые формы конденсированных гетероароматических пирролидинонов EA032291B1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462093564P 2014-12-18 2014-12-18
US201562115223P 2015-02-12 2015-02-12
US201562180222P 2015-06-16 2015-06-16
PCT/IB2015/002489 WO2016097862A2 (en) 2014-12-18 2015-12-17 Solid state forms of fused heteroaromatic pyrrolidinones

Publications (2)

Publication Number Publication Date
EA201791369A1 true EA201791369A1 (ru) 2017-10-31
EA032291B1 EA032291B1 (ru) 2019-05-31

Family

ID=55299676

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201791369A EA032291B1 (ru) 2014-12-18 2015-12-17 Твердые формы конденсированных гетероароматических пирролидинонов

Country Status (29)

Country Link
US (3) US10676473B2 (ru)
EP (2) EP3233857B1 (ru)
JP (3) JP6778195B2 (ru)
KR (1) KR102037502B1 (ru)
CN (1) CN107108609B (ru)
AU (1) AU2015365580B2 (ru)
BR (1) BR112017013149B1 (ru)
CA (1) CA2970864C (ru)
CL (1) CL2017001561A1 (ru)
CO (1) CO2017005910A2 (ru)
CR (1) CR20170249A (ru)
DK (1) DK3233857T3 (ru)
DO (1) DOP2017000130A (ru)
EA (1) EA032291B1 (ru)
EC (1) ECSP17038100A (ru)
ES (1) ES2788454T3 (ru)
GE (1) GEP20197050B (ru)
HK (1) HK1243406A1 (ru)
IL (1) IL252941B (ru)
MX (1) MX2017007162A (ru)
NZ (1) NZ732371A (ru)
PE (1) PE20171179A1 (ru)
PH (1) PH12017501123A1 (ru)
PL (1) PL3233857T3 (ru)
SG (1) SG11201701911QA (ru)
TN (1) TN2017000080A1 (ru)
UA (1) UA120632C2 (ru)
WO (1) WO2016097862A2 (ru)
ZA (1) ZA201701800B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2818103C2 (ru) * 2018-12-14 2024-04-24 Чиа Тай Тяньцин Фармасьютикал Груп Ко., Лтд. Соль ингибитора syk и ее кристаллическая форма

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3233857B1 (en) * 2014-12-18 2020-03-11 Takeda Pharmaceutical Company Limited Solid state forms of fused heteroaromatic pyrrolidinones
US20190231757A1 (en) * 2016-07-13 2019-08-01 Takeda Pharmaceutical Company Limited Combination of spleen tyrosine kinase inhibitors and other therapeutic agents
JP2020537678A (ja) 2017-10-19 2020-12-24 バイエル・アニマル・ヘルス・ゲーエムベーハー 動物における疾患の治療および予防のための縮合ヘテロ芳香族ピロリドンの使用
WO2019088039A1 (en) 2017-10-30 2019-05-09 Takeda Pharmaceutical Company Limited Treatment of acute myeloid leukemia
EP3896063B1 (en) * 2018-12-14 2024-01-24 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Crystalline forms of the syk inhibitor 5-fluoro-1-methyl-3-[[5-[4-(3-oxetanyl)-1-piperazinyl]-2-pyridinyl]amino]-6-(1h-pyrazol-3-yl)-2(1h)-quinolinone hydrochloride salt (1:1)
WO2020161663A1 (en) 2019-02-07 2020-08-13 Janssen Biotech, Inc. Dihydroorotate dehydrogenase inhibitors
TW202104207A (zh) 2019-04-17 2021-02-01 美商健生生物科技公司 二氫乳清酸脫氫酶抑制劑
EP4041714B1 (en) 2019-10-10 2023-12-13 Janssen Biotech, Inc. Bi-aryl dihydroorotate dehydrogenase inhibitors
WO2022074534A1 (en) 2020-10-05 2022-04-14 Janssen Biotech, Inc. Combinations of dihydroorotate dehydrogenase inhibitors and hypomethylating agents
WO2022127753A1 (zh) * 2020-12-18 2022-06-23 山东轩竹医药科技有限公司 稠环类AhR抑制剂
EP4337216A1 (en) 2021-05-11 2024-03-20 JANSSEN Pharmaceutica NV Combination therapies
WO2022237719A1 (en) 2021-05-11 2022-11-17 Janssen Pharmaceutica Nv Combination therapies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1960372B1 (en) * 2005-12-15 2015-12-09 Rigel Pharmaceuticals, Inc. Kinase inhibitors and their uses
GEP20156243B (en) * 2009-12-23 2015-02-10 Takeda Pharmaceutical Fused heteroaromatic pyrrolidinones as syk inhibitors
EP2723739B1 (en) * 2011-06-22 2016-08-24 Takeda Pharmaceutical Company Limited Substituted 6-aza-isoindolin-1-one derivatives
TW201625263A (zh) * 2014-09-24 2016-07-16 千禧製藥公司 利用ＰＩ３Ｋα抑制劑與紫杉烷之組合治療
EP3233857B1 (en) * 2014-12-18 2020-03-11 Takeda Pharmaceutical Company Limited Solid state forms of fused heteroaromatic pyrrolidinones

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2818103C2 (ru) * 2018-12-14 2024-04-24 Чиа Тай Тяньцин Фармасьютикал Груп Ко., Лтд. Соль ингибитора syk и ее кристаллическая форма

Also Published As

Publication number Publication date
EP3233857B1 (en) 2020-03-11
GEP20197050B (en) 2019-12-10
JP6778195B2 (ja) 2020-10-28
US20160176869A1 (en) 2016-06-23
UA120632C2 (uk) 2020-01-10
DOP2017000130A (es) 2017-07-15
EP3677582B1 (en) 2023-01-25
US20200339573A1 (en) 2020-10-29
CR20170249A (es) 2017-09-25
ES2788454T3 (es) 2020-10-21
IL252941B (en) 2020-11-30
ECSP17038100A (es) 2017-12-01
HK1243406A1 (zh) 2018-07-13
JP6974534B2 (ja) 2021-12-01
CL2017001561A1 (es) 2018-01-12
BR112017013149B1 (pt) 2022-10-11
EP3233857A2 (en) 2017-10-25
JP2017537969A (ja) 2017-12-21
WO2016097862A3 (en) 2016-08-11
ZA201701800B (en) 2020-05-27
PL3233857T3 (pl) 2020-07-27
KR102037502B1 (ko) 2019-10-28
JP2020143081A (ja) 2020-09-10
EA032291B1 (ru) 2019-05-31
US10676473B2 (en) 2020-06-09
EP3677582A1 (en) 2020-07-08
US11352355B2 (en) 2022-06-07
CN107108609A (zh) 2017-08-29
KR20170095374A (ko) 2017-08-22
SG11201701911QA (en) 2017-04-27
NZ732371A (en) 2023-04-28
IL252941A0 (en) 2017-08-31
PH12017501123A1 (en) 2017-11-27
JP2022017477A (ja) 2022-01-25
BR112017013149A2 (pt) 2018-04-10
US20230348461A1 (en) 2023-11-02
CN107108609B (zh) 2020-02-18
CA2970864C (en) 2020-04-14
TN2017000080A1 (en) 2018-07-04
WO2016097862A2 (en) 2016-06-23
CO2017005910A2 (es) 2017-10-20
AU2015365580A1 (en) 2017-07-06
DK3233857T3 (da) 2020-04-27
AU2015365580B2 (en) 2020-04-02
MX2017007162A (es) 2017-08-28
PE20171179A1 (es) 2017-08-22
CA2970864A1 (en) 2016-06-23

Similar Documents

Publication Publication Date Title
EA201791369A1 (ru) Твердые формы конденсированных гетероароматических пирролидинонов
CL2019000942A1 (es) Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret.
NZ729603A (en) Heteroaryl compounds as btk inhibitors and uses thereof
PH12016501898B1 (en) Quinoxaline derivatives useful as fgfr kinase modulators
EA032953B1 (ru) Нафтиридиновые соединения в качестве ингибиторов jak киназы
TW201613925A (en) Imidazopyrazines as LSD1 inhibitors
MX2021013118A (es) Compuestos polifluorados que actuan como inhibidores de la tirosina cinasa de bruton.
EA201691070A1 (ru) Новые трициклические соединения в качестве противораковых средств
EA201691745A1 (ru) Ингибиторы jak1 для лечения миелодиспластических синдромов
EA201590850A1 (ru) Трициклические конденсированные производные тиофена как ингибиторы jak
EA201891251A1 (ru) Бициклические ингибиторы pad4
EA201691164A1 (ru) Производные пиразоло[1,5-a]пиридина и способы их применения
EA201690502A1 (ru) Замещенные пиримидиновые ингибиторы bmi-1
EA201790395A1 (ru) Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы
EA201591689A1 (ru) НОВЫЕ N-АЦИЛ-(3-ЗАМЕЩЕННЫЕ)-(8-ЗАМЕЩЕННЫЕ)-5,6-ДИГИДРО[1,2,4]ТРИАЗОЛО[4,3-a]ПИРАЗИНЫ КАК СЕЛЕКТИВНЫЕ АНТАГОНИСТЫ РЕЦЕПТОРА NK-3, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И МЕТОДЫ ИСПОЛЬЗОВАНИЯ ПРИ РАССТРОЙСТВАХ,ОПОСРЕДОВАННЫХ РЕЦЕПТОРОМ NK-3
MA50375A (fr) Compositions contenant des composés substitués de [1,2,4]triazolo[1,5-a]pyrimidine-7-yl utilisés en tant qu'inhibiteurs pde2
EA201592238A1 (ru) Ингибиторы протеинкиназы pi3k, в частности ингибиторы pi3k дельта и/или гамма
MD20150071A2 (ru) Азабензимидазольные соединения в качестве ингибиторов изоферментов PDE4 для лечения расстройств ЦНС и других расстройств
EA201790603A1 (ru) Ингибиторы гистондеметилазы
MA46690A (fr) Composés de [1,2,4]triazolo [1,5-a]pyrimidine en tant qu'inhibiteurs de pde2
MX2016009655A (es) Metodos novedosos para el tratamiento del cancer.
PH12016501393A1 (en) Substituted bicyclic heteroaryl compounds as rxr agonists
MY195169A (en) Cyclic Ether Derivatives of Pyrazolo[1,5-A]Pyrimidine-3-Carboxyamide
EA201792445A1 (ru) Новые амидогетероарилароилгидразидэтины
EA201692227A1 (ru) Производные сложных аминоэфиров